Best treatments for precursor cell lymphoblastic leukemia-lymphoma
9 products may treat precursor cell lymphoblastic leukemia-lymphoma, spanning FDA drug classes such as anthracycline topoisomerase inhibitor, cd22-directed immunoconjugate, leukocyte growth factor. The current highest-rated option is elspar. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 9 drugs we list for precursor cell lymphoblastic leukemia-lymphoma, 1 is available as lower-cost generics, spanning classes such as anthracycline topoisomerase inhibitor, cd22-directed immunoconjugate, leukocyte growth factor. 5 of 9 carry a safety score, from 60 to 72 out of 100. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for precursor cell lymphoblastic leukemia-lymphoma — so confirm the right choice with your prescriber.
Top-rated picks for precursor cell lymphoblastic leukemia-lymphoma: 1. Elspar · 2. Idarubicin Hydrochloride · 3. Purinethol
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | — | No data | — | View → | |
| 2 | 72/100 | Prescription | Injectable | Anthracycline Topoisomerase Inhibitor | No data | — | View → | |
| 3 | 72/100 | Prescription | Tablet | — | Generic | $30 | View → | |
| 4 | 66/100 | Prescription | Injectable | Anthracycline Topoisomerase Inhibitor | No data | — | View → | |
| 5 | 60/100 | Prescription | Solution | Anthracycline Topoisomerase Inhibitor | No data | — | View → | |
| 6 | Not yet rated | Prescription | Injectable | CD22-directed Immunoconjugate | No data | — | View → | |
| 7 | Not yet rated | Prescription | Injectable | Leukocyte Growth Factor | No data | — | View → | |
| 8 | Not yet rated | Prescription | Injectable | — | No data | — | View → | |
| 9 | Not yet rated | Prescription | Injectable | — | No data | — | View → |
Narrow by drug class
Explore the class hubs: anthracycline topoisomerase inhibitor
Full ranking · 9 treatments
elspar
PrescriptionFDA-sourced
Elspar (Asparaginase) is a medication used to treat Cholelithiasis, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
idarubicin hydrochloride
Boxed warningPrescriptionFDA-sourced
Idarubicin Hydrochloride is an anthracycline topoisomerase inhibitor used to treat Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
purinethol
PrescriptionFDA-sourced
Purinethol (Mercaptopurine) is a medication used to treat Non-Hodgkin Lymphoma, B-Cell Chronic Lymphocytic Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Pharmacy pays
~$30.33 /30
daunorubicin hydrochloride
PrescriptionFDA-sourced
Daunorubicin Hydrochloride is an anthracycline topoisomerase inhibitor used to treat Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
idamycin pfs
Boxed warningPrescriptionFDA-sourced
Idamycin Pfs (Idarubicin Hydrochloride) is an anthracycline topoisomerase inhibitor used to treat Breast Neoplasms, Bcr-Abl Positive Chronic Myelogenous Leukemia, Acute Myeloid Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
besponsa
Boxed warningPrescriptionFDA-sourced
Besponsa (Inotuzumab Ozogamicin) is a cd22-directed immunoconjugate used to treat Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Price varies
Frequently asked
- What treats precursor cell lymphoblastic leukemia-lymphoma?
- Our catalog lists 9 products that may treat precursor cell lymphoblastic leukemia-lymphoma, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is elspar.
- What is the best-rated treatment for precursor cell lymphoblastic leukemia-lymphoma?
- By our independent recall-safety rating — not an efficacy measure — elspar ranks highest among the products we list for precursor cell lymphoblastic leukemia-lymphoma. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat precursor cell lymphoblastic leukemia-lymphoma?
- Treatments for precursor cell lymphoblastic leukemia-lymphoma span FDA drug classes including anthracycline topoisomerase inhibitor, cd22-directed immunoconjugate, leukocyte growth factor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status